Marketplace Enrollment Still Important Despite Plans For Health Law Repeal
Republicans’ plans to overhaul the federal health law are not expected to take effect immediately, so consumers can still sign up for 2017 coverage.
U.S. Congress
961 - 980 of 989 Results
-
-
Retired Coal Miners At Risk Of Losing Promised Health Coverage And Pensions
A fund guaranteeing health coverage and pensions to retired mine workers is about to run dry. Congress has been reluctant to pick up the tab. Democrats from coal country say it's time to act.
-
Interstate Health Insurance Sales Has A Tryout In Georgia But No Takers
In 2011 the state, seeking to attract lower-cost insurance, enacted a law letting insurers sell any policy that they offer in other states, but no health insurer has taken advantage of it.
-
Grab Bag Of Goodies In 21st Century Cures Act
A breakdown of winners — and a few losers — in the sprawling Cures Act approved by the House.
By Sydney Lupkin and Steven Findlay -
Senate Approves Landmark Mental Health Bill As Part Of 21st Century Cures Act
The U.S. Senate passed a landmark bill to help millions of Americans suffering from mental illness.
By Liz Szabo -
Health Law’s Test Kitchen For Payment Reforms Could Offer Tool For GOP Ideas
The Centers for Medicare & Medicaid Innovation was charged by the health law with exploring payment reforms that could cut health care costs and possibly improve quality. But its future is hinged to whether GOP lawmakers see value in its work.
-
Legislation To Improve Mental Health Care For Millions Sails Through House Vote
Sponsors of Congressional action up for vote Wednesday have championed mental health changes since the 2012 Newtown shootings.
By Liz Szabo -
Price’s Appointment Boosts GOP Plans To Overhaul Medicare And Medicaid
Privatizing the Medicare program for the elderly and disabled and turning the Medicaid program for the poor back to the states are long-time goals for Republicans in Congress and the White House.
By Julie Rovner -
A Frenzy Of Lobbying On 21st Century Cures
Three lobbyists for every member of Congress in a push to pass a bill that increases research funding and speeds up approvals.
-
Back To The Future: Insurance Pools For High-Risk Patients Could Be Revived
Trump and leading Republicans like the idea. Some policymakers and experts say it wasn’t viable in the first place.
-
Long-Stalled FDA Reform Sits On Senate’s Lame-Duck Calendar
The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patients’ safety and doesn’t do enough to stop spiraling drug prices.
-
Blue Shield, California’s Biggest Obamacare Insurer, Vows It’s Not ‘Running For The Hills’
The company’s CEO also dismisses Trump’s notion of selling insurance plans across state lines, calling it ‘perplexing.’
By Chad Terhune -
Elections 2016
Millions Could Lose Medicaid Coverage Under Trump Plan
But block grants face likely resistance from states, poised to lose many millions.
-
Elections 2016
Repealing The Affordable Care Act Could Be More Complicated Than It Looks
Republicans will likely chip away at the ACA piecemeal and say they will try to provide a soft exit.
By Julie Rovner -
Elections 2016
Trump, GOP In Congress Could Use ‘Must-Pass’ Bills To Bring Health Changes
Some “must-pass” health legislation next year could give the new administration a vehicle for some proposals that might not be able to clear political or procedural hurdles on their own.
By Julie Rovner -
What Would A Public Insurance Option Look Like?
UCLA health policy expert Gerald Kominski says a “public option” health plan would look a lot like private insurance, and politics will determine whether it would happen on a state or national level.
-
A Bygone Era: When Bipartisanship Led To Health Care Transformation
A federal law enacted shortly after the end of World War II provided grants and loans to fund hospital construction that have left a lasting legacy.
-
The Orphan Drug Machine
A Golden Ticket That Fast-Tracks A Drug Through The FDA
A voucher awarded to companies that find treatments for rare childhood diseases can be sold to the highest bidder — and then used to speed up approvals for much more common drugs.
-
Congressman Decries Olympus’ Failure To Warn U.S. Hospitals About Tainted Scopes
U.S. Rep. Ted Lieu (D-Calif.) renews his call for tightened laws that would force manufacturers to notify the Food and Drug Administration when they issue safety warnings in other countries related to the design and cleaning of their devices.
By Chad Terhune -
Seven Remaining Obamacare Co-Ops Prepare Survival Strategies
Two-thirds of the federally funded co-ops created by the health law to sell health insurance to individuals and small employers have folded and those that remain are diversifying to stay alive.